GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CardioGenics Holdings Inc (OTCPK:CGNH) » Definitions » Total Liabilities

CardioGenics Holdings (CardioGenics Holdings) Total Liabilities : $2.35 Mil (As of Jan. 2016)


View and export this data going back to 2004. Start your Free Trial

What is CardioGenics Holdings Total Liabilities?

CardioGenics Holdings's Total Liabilities for the quarter that ended in Jan. 2016 was $2.35 Mil.

CardioGenics Holdings's quarterly Total Liabilities declined from Jul. 2015 ($1.87 Mil) to Oct. 2015 ($1.80 Mil) but then increased from Oct. 2015 ($1.80 Mil) to Jan. 2016 ($2.35 Mil).

CardioGenics Holdings's annual Total Liabilities declined from Oct. 2013 ($1.47 Mil) to Oct. 2014 ($1.43 Mil) but then increased from Oct. 2014 ($1.43 Mil) to Oct. 2015 ($1.80 Mil).


CardioGenics Holdings Total Liabilities Historical Data

The historical data trend for CardioGenics Holdings's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CardioGenics Holdings Total Liabilities Chart

CardioGenics Holdings Annual Data
Trend Jul06 Jul07 Jul08 Oct09 Oct10 Oct11 Oct12 Oct13 Oct14 Oct15
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.63 0.89 1.47 1.43 1.80

CardioGenics Holdings Quarterly Data
Apr11 Jul11 Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Jul15 Oct15 Jan16
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.82 1.55 1.87 1.80 2.35

CardioGenics Holdings Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

CardioGenics Holdings's Total Liabilities for the fiscal year that ended in Oct. 2015 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1.795+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=1.80

Total Liabilities=Total Assets (A: Oct. 2015 )-Total Equity (A: Oct. 2015 )
=0.232--1.563
=1.80

CardioGenics Holdings's Total Liabilities for the quarter that ended in Jan. 2016 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2.345+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=2.35

Total Liabilities=Total Assets (Q: Jan. 2016 )-Total Equity (Q: Jan. 2016 )
=0.558--1.787
=2.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CardioGenics Holdings Total Liabilities Related Terms

Thank you for viewing the detailed overview of CardioGenics Holdings's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


CardioGenics Holdings (CardioGenics Holdings) Business Description

Traded in Other Exchanges
N/A
Address
6295 Northam Drive, Unit 8, Mississauga, ON, CAN, L4V 1W8
CardioGenics Holdings Inc is a biotechnology company. It is engaged in the development and commercialization of diagnostic test products for the In-Vitro Diagnostics (IVD) testing market. The company's objective is to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies. Its products include QL Care Analyzer, Immunoassay Tests, and Paramagnetic Beads. The business activity is primarily carried out through the region of Canada.

CardioGenics Holdings (CardioGenics Holdings) Headlines

No Headlines